Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women

Pharmacological Research

Volumn 54, Issue 4, 2006, Pages 298-302

  Vural, Pervin ^a   Akgul, Cemil ^a   Canbaz, Mukaddes ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bone turnover; Cytokines; Hormone replacement therapy (HRT); Menopause

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYTOKINE; HYDROXYPROLINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MEDROXYPROGESTERONE ACETATE; OXALIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE METABOLISM; BONE TURNOVER; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CELL ACTIVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYDROXYPROLINE URINE LEVEL; INFLAMMATION; KRUSKAL WALLIS TEST; NORMAL HUMAN; OSTEOCLAST; OSTEOLYSIS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; POST HOC ANALYSIS; POSTMENOPAUSE; PRECIPITATION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL; TITRIMETRY; TREATMENT DURATION; WILCOXON SIGNED RANKS TEST;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE AND BONES; CALCIUM; CYTOKINES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; HYDROXYPROLINE; INTERLEUKIN-1; INTERLEUKIN-10; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747192680     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.06.006     Document Type: Article

References (45)

1. Siggelkow H., Eidner T., Lehmann G., Viereck V., Raddatz D., Munzel U., et al. Cytokines, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone disease. J Bone Miner Res 18 (2003) 529-538
2. Gowen M., Wood D.D., and Russell R.G.G. Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. J Clin Invest 75 (1985) 1223-1229
3. Lorenzo J.A., Sousa S.I., Alander C., Raisz L.G., and Dinarello C.A. Comparison of the bone-resorbing activity in the supernatants from phytohemaglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of antiserum to interleukin 1. Endocrinology 121 (1987) 1164-1170
4. Boyce B.F., Aufdemorte T.B., Garrett I.R., Yates A.J.P., and Mundy G.R. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125 (1989) 1142-1150
5. Sabatini M., Boyce B., Aufdemorte T., Bonewald L., and Mundy G.R. Infusions of recombinant human interleukin 1alfa and beta cause hypercalcemia in normal mice. Proc Natl Acad Sci USA 85 (1988) 5235-5239
6. Johnson R.A., Boyce B.F., Mundy G.R., and Roodman G.D. Tumors producing tumor necrosis factor induced hypercalcemia and osteoblastic bone resorption in nude mice. Endocrinology 124 (1989) 1424-1427
7. Thomson B.M., Mundy G.R., and Chambers T.J. Tumor necrosis factor α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138 (1987) 775-779
8. Thomson B.M., Saklatvala J., and Chambers T.J. Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164 (1986) 1004-1112
9. Pfeilschifter J., Chenu C., Bird A., Mundy G.R., and Roodman G.D. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4 (1989) 113-118
10. Girasole G., Jilka R.L., Passer G., Boswell S., Boder G., Williams D.C., et al. 17β-Estradiol inhibits interleukin-6 production by the bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89 (1992) 883-891
11. Male D., Cooke A., Owren M., Trowsdale J., and Champion B. Advanced immunology (1996), C.V. Mosby, St. Louis
12. Revilard J.P. Immunologie. 2nd ed. (1995), De boeck & Larcier SA, Paris
13. Berger S., Ballo H., and Stutte H.J. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio. Eur J Immunol 26 (1996) 1297-1301
14. Onoe Y., Miyaura C., Kaminakayashiki T., Nagi Y., Nogushi K., Chen O.R., et al. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 156 (1996) 758-764
15. Akgül C., Canbaz M., Vural P., Yildirim A., and Geren N. Hormone replacement therapy and urinary prostaglandins in postmenopausal women. Maturitas 30 (1998) 79-83
16. Manolagas S.C., and Jilka R.L. Bone marrow, cytokines, and bone remodeling. N Engl J Med 332 (1995) 305-311
17. Kameda T., Mano H., Yuasa T., Mori Y., Miyazawa K., Shiokawa M., et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186 (1997) 489-495
18. Hughes D.E., Dai A., Tiffee J.C., Li H.H., Mundy G.R., and Boyce B.F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 2 (1996) 1132-1136
19. Kawaguchi H., Pilbeam C.C., Vargas S.J., Morse E.E., Lorenzo J.A., and Raisz L.G. Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest 96 (1995) 539-548
20. Hannon R., Blumsohn A., Naylor K., and Eastell R. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 14 (1999) 470-472
21. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11 (1996) 1043-1051
22. Manolagas S.C., and Jilka R.L. Bone marrow, cytokines, and bone remodeling. N Engl J Med 332 (1995) 305-311
23. Genci S., Weitzmann M.N., Roggia C., Namba N., Novack D., Woodring J., et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α. J Clin Invest 106 (2000) 1229-1237
24. Srivastava S., Toraldo G., Weitzmann M.N., Genci S., Ross F.P., and Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κB ligand (RANKL)-induced JNK activation. J Biol Chem 276 (2001) 8836-8840
25. Porter V.R., Greendale G.A., Schocken M., Zhu X., and Effros R.B. Immune effects of hormone replacement therapy in postmenopausal women. Exp Gerontol 36 (2001) 311-326
26. Cioffi M., Esposito K., Vietri M.T., Gazzerro P., D'Auria A., ArdovinoI, et al. Cytokine pattern in postmenopause. Maturitas 41 (2002) 187-192
27. Berg G., Ekerfelt C., Hammar M., Lindgren R., Matthisen L., and Ernerudh C. Cytokine changes in postmenopausal women treated with estrogen: a placebo-controlled study. Am J Reprod Immunol 48 (2002) 63-69
28. Saucedo R., Rico G., Basutro L., Ochoa R., and Zarafe A. Transdermal estradiol in menopausal women depresses interleukin-6 without effecting other markers of immune response. Gynecol Obstet Invest 53 (2002) 114-117
29. Switzer B.R. Determination of hydroxyproline in tissue. Met Nutr Biochem 2 (1991) 229-231
30. Faulkner W.R., and King W.J. Renal function. In: Tietz N.W. (Ed). Fundamentals of clinical chemistry. 2nd ed. (1982), Saunders Co., Philadelphia 975-1014
31. Tietz N.W. Blood gases and electrolytes. In: Tietz N.W. (Ed). Fundamentals of clinical chemistry. 2nd ed. (1982), Saunders Co, Philadelphia 849-944
32. Cohen-Solal M.E., Graulet A.M., Denne M.A., Gueris J., Baylink D., and de Vernejoul M.C. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 77 (1993) 1648-1653
33. Pfeilschifter J., Koditz R., Pfohl M., and Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23 (2002) 90-119
34. Pacifici R., Rifas L., McCraken R., Vered I., McMurty C., Avioli L.V., et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86 (1989) 2398-2402
35. Vural P., Akgul C., and Canbaz M. Effects of menopause and tibolone on antioxidants in postmenopausal women. Ann Clin Biochem 42 (2005) 220-223
36. Isomura H., Fujie K., Shibata K., Inoue N., Iizuka T., Takebe G., et al. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197 (2004) 93-100
37. Wang Y., Walsh S.W., and Kay H.H. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 167 (1992) 946-949
38. Lorenzo J.A., Naprta A., Rao Y., Alander C., Glaccum M., Widmer M., et al. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 139 (1998) 3022-3025
39. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88 (1991) 5134-5138
40. Rogers A., and Eastell R. The effect of 17β-estradiol on production of cytokines in cultures of periferal blood. Bone 29 (2001) 30-34
41. Ralston S.H. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9 (1994) 883-890
42. Wolinsky H. Effects of estrogen and progesterone treatment on the responses of the aorta of male rats to hypertension. Morphological chemical studies. Circ Res 30 (1972) 341-349
43. Pacifici R. Aging and cytokine production. Calcif Tissue Int 65 (1999) 345-351
44. Ruh M.F., Bi Y., Cox L., Berk D., Howlett A.C., and Bellone C.J. Effect of environmental estrogen on IL-1 beta promoter activity in a macrophage cell line. Endocrinology 9 (1998) 207-211
45. Ruh M.F., Bi Y., D'Alonzo R., and Bellone C.J. Effect of estrogens on IL-1 beta promoter activity. J Steroid Biochem Mol Biol 66 (1998) 203-210